NASDAQ: VRTXVertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?
Insider buying vs selling
Have Vertex Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Duncan McKechnie | EVP Chief Commercial Officer | 2026-07-02 | 1,541 | $519.00 | $799.78kSell |
| Ourania Tatsis | EVP Chief Reg. Quality Off. | 2026-07-02 | 1,500 | $524.99 | $787.49kSell |
| Joy Liu | EVP and Chief Legal Officer | 2026-07-01 | 828 | $502.71 | $416.24kSell |
| Carmen Bozic | EVP and CMO | 2026-06-26 | 596 | $482.50 | $287.57kSell |
| Carmen Bozic | EVP and CMO | 2026-06-18 | 1,020 | $462.17 | $471.41kSell |
| Carmen Bozic | EVP and CMO | 2026-06-15 | 4,062 | $450.00 | $1.83MSell |
| Carmen Bozic | EVP and CMO | 2026-06-05 | 1,745 | $450.00 | $785.25kSell |
| Joy Liu | EVP and Chief Legal Officer | 2026-06-01 | 828 | $439.91 | $364.25kSell |
| Carmen Bozic | EVP and CMO | 2026-05-29 | 1,974 | $450.00 | $888.30kSell |
| Mark E. Bunnage | EVP Chief Scientific Officer | 2026-05-15 | 33 | $453.45 | $14.96kSell |
VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VRTX insiders and whales buy or sell their stock.
VRTX Shareholders
What type of owners hold Vertex Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joshua S. Boger | 0.52% | 1,310,971 | $663.02M | Insider |
| Assenagon Asset Management Sa | 0.30% | 759,564 | $384.15M | Institution |
| Kenneth S. Boger | 0.12% | 301,082 | $152.27M | Insider |
| Swedbank Ab | 0.11% | 282,444 | $142.85M | Institution |
| Handelsbanken Fonder Ab | 0.09% | 218,292 | $110.40M | Institution |
| Davenport Co LLC 1 | 0.08% | 207,108 | $104.74M | Institution |
| Matthew Emmens | 0.08% | 200,873 | $101.59M | Insider |
| Peter Mueller | 0.08% | 193,796 | $98.01M | Insider |
| John J. Alam | 0.06% | 141,932 | $71.78M | Insider |
| Country Trust Bank | 0.04% | 100,360 | $50.76M | Institution |
VRTX vs Biotech Stocks
Vertex Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.